Diagnostics specialist Lantheus, capitalised at $8 billion on the Nasdaq, likes the look of Aussie Radiopharm Theranostics.
Street Talk understands Lantheus has agreed to pay a 47 per cent premium to Radiopharm’s last close to come in as a cornerstone investor on an equity raise of up to $65 million. It will tip in $US7 million at 5¢ a share, with the option to top up by another $US5 million.
Ann: Trading Halt, page-29
-
- There are more pages in this discussion • 19 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.7¢ |
Change
-0.001(2.63%) |
Mkt cap ! $39.12M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $51.17K | 1.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 437289 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.9¢ | 216900 | 2 |
View Market Depth
| Last trade - 16.10pm 12/07/2024 (20 minute delay) ? |
| RAD (ASX) Chart |